{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:23:40Z","timestamp":1787743420073,"version":"build-2784847793"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["OPP1033514"],"award-info":[{"award-number":["OPP1033514"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["OPP1172799"],"award-info":[{"award-number":["OPP1172799"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"crossref","award":["R01 HD087119"],"award-info":[{"award-number":["R01 HD087119"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"crossref","award":["R21 HD090987"],"award-info":[{"award-number":["R21 HD090987"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011072","name":"Center for AIDS Research, University of North Carolina at Chapel Hill","doi-asserted-by":"crossref","award":["P30 AI50410"],"award-info":[{"award-number":["P30 AI50410"]}],"id":[{"id":"10.13039\/100011072","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"crossref","award":["P30 AI50410"],"award-info":[{"award-number":["P30 AI50410"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","award":["T32 HD075731"],"award-info":[{"award-number":["T32 HD075731"]}]},{"DOI":"10.13039\/100011485","name":"North Carolina Translational and Clinical Sciences Institute, University of North Carolina at Chapel Hill","doi-asserted-by":"crossref","award":["UL1TR002489"],"award-info":[{"award-number":["UL1TR002489"]}],"id":[{"id":"10.13039\/100011485","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To evaluate the association between maternal HIV infection and preeclampsia. We hypothesized that maternal HIV infection would be associated with a lower risk of preeclampsia, potentially due to HIV-related immunomodulatory effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      We combined participants from one observational cohort and two randomized trials conducted at the same facilities in Lusaka, Zambia between 2015 and 2022. The exposure of interest was maternal HIV infection, and the primary outcome was\n                      <jats:italic toggle=\"yes\">preeclampsia<\/jats:italic>\n                      , defined as 1) new-onset (at or after 20 weeks of gestation) hypertension (systolic blood pressure [BP] 140 mm Hg or higher or diastolic BP 90 mm Hg or higher) with concurrent proteinuria (1+ or higher), 2) new onset proteinuria (1+ or higher) in participants with chronic hypertension in the absence of urinary tract infection, or 3) diagnosis of severe preeclampsia. We defined\n                      <jats:italic toggle=\"yes\">severe preeclampsia<\/jats:italic>\n                      as 1) new-onset severe-range BP (systolic 160 mm Hg or higher or diastolic 110 mm Hg or higher), 2) eclamptic seizure, or 3) clinician-initiated preterm delivery (before 37 weeks of gestation) for preeclampsia. Using marginal standardization (parametric g-formula), we estimated the risk of preeclampsia associated with HIV infection. Antiretroviral therapy (ART) exposure and HIV disease severity (viral load, CD4 counts) were assessed as effect modifiers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Of 4,078 women included in the combined cohort, 186 (4.6%) were diagnosed with preeclampsia, including 43 (2.7%) of 1,590 women with HIV infection and 143 (5.8%) of 2,488 women without HIV infection. Of those with HIV infection, 73.2% were on prepregnancy ART, and 56.7% had an undetectable viral load at study enrollment (median 15 weeks). In analyses standardizing for maternal age, nulliparity, and calendar time of enrollment, HIV infection was associated with lower preeclampsia risk (relative risk 0.42; 95% CI, 0.26\u20130.59; risk difference \u22123.5%; 95% CI, \u22124.9 to \u22122.1). This reduced risk persisted when stratifying by prepregnancy ART exposure, detectable viral load, and CD4 count at enrollment; findings were similar when applying the more stringent definition of severe preeclampsia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>In this well-phenotyped cohort, women with HIV infection were less likely to have preeclampsia compared with those without HIV infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000005970","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T17:04:27Z","timestamp":1749747867000},"page":"413-421","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Maternal Human Immunodeficiency Virus and Preeclampsia Among a Combined Cohort of Zambian Women"],"prefix":"10.1097","volume":"146","author":[{"given":"Katelyn J.","family":"Rittenhouse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret P.","family":"Kasaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Bridget","family":"Spelke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri V.","family":"Sebasti\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humphrey","family":"Mwape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Chanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Mandona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ntazana","family":"Sindano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Stringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bellington","family":"Vwalika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S. A.","family":"Stringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"R1-20260826","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob Health"},{"key":"R2-20260826","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12884-021-03809-2","article-title":"Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population\u2010based study","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"key":"R3-20260826","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: pathophysiology, challenges, and perspectives","volume":"124","author":"Rana","year":"2019","journal-title":"Circ Res"},{"key":"R4-20260826","doi-asserted-by":"crossref","first-page":"9157","DOI":"10.3390\/ijms22179157","article-title":"HIV associated preeclampsia: a multifactorial appraisal","volume":"22","author":"Naicker","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R7-20260826","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/QAD.0b013e32835fd940","article-title":"The contribution of HIV to pregnancy-related mortality: a systematic review and meta-analysis","volume":"27","author":"Calvert","year":"2013","journal-title":"AIDS"},{"key":"R8-20260826","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.preghy.2019.05.015","article-title":"Combined antiretroviral therapy for HIV and the risk of hypertensive disorders of pregnancy: a systematic review","volume":"17","author":"Premkumar","year":"2019","journal-title":"Pregnancy Hypertens"},{"key":"R9-20260826","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijgo.2015.08.007","article-title":"A systematic review of the effect of HIV infection and antiretroviral therapy on the risk of pre-eclampsia","volume":"133","author":"Adams","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"key":"R10-20260826","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/QAI.0000000000000686","article-title":"HIV, antiretroviral therapy, and hypertensive disorders in pregnancy: a systematic review and meta-analysis","volume":"70","author":"Browne","year":"2015","journal-title":"J Acquir Immun Defic Syndr"},{"key":"R11-20260826","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12884-019-2224-8","article-title":"Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial","volume":"19","author":"Price","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"R12-20260826","doi-asserted-by":"crossref","first-page":"e605","DOI":"10.1016\/S2352-3018(21)00150-8","article-title":"Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trial","volume":"8","author":"Price","year":"2021","journal-title":"Lancet HIV"},{"key":"R13-20260826","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40814-017-0170-7","article-title":"Vaginal progesterone to reduce preterm birth among HIV-infected pregnant women in Zambia: a feasibility study protocol","volume":"4","author":"Price","year":"2018","journal-title":"Pilot Feasibility Stud"},{"key":"R14-20260826","doi-asserted-by":"crossref","first-page":"e0224874","DOI":"10.1371\/journal.pone.0224874","article-title":"Vaginal progesterone to prevent preterm delivery among HIV-infected pregnant women in Zambia: a feasibility study","volume":"15","author":"Price","year":"2020","journal-title":"PLoS One"},{"key":"R15-20260826","doi-asserted-by":"crossref","first-page":"25","DOI":"10.12688\/gatesopenres.12820.1","article-title":"The Zambian Preterm Birth Prevention Study (ZAPPS): Cohort characteristics at enrollment","volume":"2","author":"Castillo","year":"2018","journal-title":"Gates Open Res"},{"key":"R16-20260826","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.12688\/gatesopenres.13046.1","article-title":"Adverse birth outcomes and their clinical phenotypes in an urban Zambian cohort","volume":"3","author":"Price","year":"2019","journal-title":"Gates Open Res"},{"key":"R19-20260826","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/aje\/kwx348","article-title":"Principled approaches to missing data in epidemiologic studies","volume":"187","author":"Perkins","year":"2018","journal-title":"Am J Epidemiol"},{"key":"R20-20260826","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/aje\/kwx349","article-title":"Multiple imputation for incomplete data in epidemiologic studies","volume":"187","author":"Harel","year":"2018","journal-title":"Am J Epidemiol"},{"key":"R21-20260826","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/EDE.0000000000000160","article-title":"The parametric g-Formula for time-to-event data: intuition and a worked example","volume":"25","author":"Keil","year":"2014","journal-title":"Epidemiology"},{"key":"R23-20260826","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/aje\/kwaa044","article-title":"Estimating risk ratios and risk differences using regression","volume":"189","author":"Naimi","year":"2020","journal-title":"Am J Epidemiol"},{"key":"R24-20260826","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/00031305.1983.10483087","article-title":"A leisurely look at the bootstrap, the jackknife, and cross-validation","volume":"37","author":"Efron","year":"1983","journal-title":"Am Statistician"},{"key":"R25-20260826","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"key":"R26-20260826","doi-asserted-by":"crossref","first-page":"e0238748","DOI":"10.1371\/journal.pone.0238748","article-title":"Acceptability of a trial of vaginal progesterone for the prevention of preterm birth among HIV-infected women in Lusaka, Zambia: a mixed methods study","volume":"15","author":"Price","year":"2020","journal-title":"PLoS One"},{"key":"R27-20260826","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejogrb.2016.12.008","article-title":"The impact of highly active antiretroviral therapy on obstetric conditions: a review","volume":"210","author":"Sebitloane","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R28-20260826","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0140-6736(02)11195-0","article-title":"Pre-eclampsia, antiretroviral therapy, and immune reconstitution","volume":"360","author":"Wimalasundera","year":"2002","journal-title":"Lancet (London, England)"},{"key":"R29-20260826","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijgo.2016.03.014","article-title":"A retrospective study of HIV, antiretroviral therapy, and pregnancy-associated hypertension among women in Lusaka, Zambia","volume":"134","author":"Stoner","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"key":"R30-20260826","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1701-2163(16)35156-8","article-title":"Risk of preeclampsia in HIV-positive pregnant women receiving HAART: a matched cohort study","volume":"34","author":"Boyajian","year":"2012","journal-title":"J Obstet Gynaecol Can"},{"key":"R31-20260826","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/01.aids.0000198090.70325.bd","article-title":"Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy","volume":"20","author":"Suy","year":"2006","journal-title":"AIDS"},{"key":"R32-20260826","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jinf.2013.12.018","article-title":"Hypertension, preeclampsia and eclampsia among HIV-infected pregnant women from Latin America and Caribbean countries","volume":"68","author":"Machado","year":"2014","journal-title":"J Infect"},{"key":"R33-20260826","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/AOG.0000000000001424","article-title":"Risk of preeclampsia in human immunodeficiency virus\u2013infected pregnant women","volume":"127","author":"Sansone","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R34-20260826","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2702.2006.01438.x","article-title":"A comparison of HIV positive and negative pregnant women at a public sector hospital in South Africa","volume":"15","author":"Bodkin","year":"2006","journal-title":"J Clin Nurs"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005970","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:02:25Z","timestamp":1787742145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005970","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]},"assertion":[{"value":"2025-01-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}